Crinetics Pharmaceuticals, Inc. ( CRNX) - Stock Earnings
Stock symbol CRNX is outdated, potentially delisted? Maybe it is available on other exchange?
CRNX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
CRNX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -122.8 million USD | 6.2 million USD |
| 2026Q1 | -127.8 million USD | 10.7 million USD |
| 2026Q2 | -120.9 million USD | 25.1 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CRNX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -214.5 million USD | 4.0 million USD |
| 2024 | -298.4 million USD | 1.0 million USD |
| 2025 | -465.3 million USD | 7.7 million USD |
| 2026 Est. | — | — |
CRNX
Price: $84.95
52 week price:
Earnings Per Share: -5.05 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 265100
Market Capitalization: 8.9 billion